238 related articles for article (PubMed ID: 9269898)
1. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40.
Raptis L; Brownell HL; Corbley MJ; Wood KW; Wang D; Haliotis T
Cell Growth Differ; 1997 Aug; 8(8):891-901. PubMed ID: 9269898
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
3. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
4. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
[TBL] [Abstract][Full Text] [Related]
5. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
6. [The effect of Ha-ras oncogene on cells immortalized by the gene for polyomavirus large T-antigen].
Komissarova EV; Spitkovskiĭ DD; Mazurenko NN; Tatosian AG
Mol Gen Mikrobiol Virusol; 1990 Feb; (2):19-22. PubMed ID: 2185418
[TBL] [Abstract][Full Text] [Related]
7. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
8. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
[TBL] [Abstract][Full Text] [Related]
9. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
Kivinen L; Pitkänen K; Laiho M
Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of c-Ras upon transformation, adipocytic differentiation, and apoptosis mediated by the simian virus 40 large tumor antigen.
Cao J; Arulanandam R; Vultur A; Anagnostopoulou A; Raptis L
Biochem Cell Biol; 2007 Feb; 85(1):32-48. PubMed ID: 17464343
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras.
Soejima K; Fang W; Rollins BJ
Oncogene; 2003 Jul; 22(30):4723-33. PubMed ID: 12879017
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
13. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
[TBL] [Abstract][Full Text] [Related]
14. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
16. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
17. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
Kaplan JB
Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
[TBL] [Abstract][Full Text] [Related]
18. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
[TBL] [Abstract][Full Text] [Related]
19. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
20. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
